TherapeuticsMD Announces Pricing of $30 Million Public Offering of Common Stock

    0
    10

    BOCA RATON, Fla. –(BUSINESS WIRE)–Nov. 10, 2020– TherapeuticsMD, Inc. (NASDAQ:TXMD) today announced the pricing of its underwritten public offering of approximately 23.4 million shares of its common stock for gross proceeds of $30 million , before deducting the underwriting discounts and

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here